Literature DB >> 2555398

Antibodies to cytomegalovirus in renal allograft recipients: correlation with isolation of virus.

J Dolan1, J D Briggs, G B Clements.   

Abstract

A cohort of 47 renal transplant recipients was studied prospectively for up to one year after transplantation. Cytomegalovirus (CMV) was isolated from 21 of the patients. The first time the virus was isolated seven patients were IgM positive, nine showed a significant rise in IgG titres, and 12 had a four-fold or greater rise in complement fixation titre. There was no significant difference in the time at which virus was first detected following transplantation between patients with primary CMV infection and those with reinfection or recurrent infection. In general, patients with primary infection shed virus consistently over long periods. Those with reinfection or recurrent infection shed virus intermittently or not at all. There were considerable differences between individual patients in the timing and pattern of the immune response. Taken overall, a four-fold rise detected by the complement fixation test correlated best with the onset of CMV shedding in primary infection. There was more variation in the pattern of antibody response in cases of reinfection or recurrent infection, with no single serological test correlating better than the others. It is concluded that serology is of limited value in the detection of active CMV infection after renal transplantation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555398      PMCID: PMC501866          DOI: 10.1136/jcp.42.10.1070

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Patterns of cytomegaloviral complement-fixing antibody activity: a longitudinal study of blood donors.

Authors:  J L Waner; T H Weller; S V Kevy
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

2.  Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections.

Authors:  R F Pass; P D Griffiths; A M August
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

Review 3.  Cytomegalovirus infection in transplant patients.

Authors:  R F Betts
Journal:  Prog Med Virol       Date:  1982

4.  Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation.

Authors:  J D Whelchel; R F Pass; A G Diethelm; R J Whitley; C A Alford
Journal:  Transplantation       Date:  1979-12       Impact factor: 4.939

5.  Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.

Authors:  S D Gardner; E F MacKenzie; C Smith; A A Porter
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

6.  Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T M Bakir; H Stern; H Kangro; P D Griffiths; R B Heath
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

7.  Specific IgM class antibody production following infection with cytomegalovirus.

Authors:  H O Kangro; P D Griffiths; T J Huber; R B Heath
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

8.  The effects of viral infections on renal transplants and their recipients.

Authors:  M J Warrell; I Chinn; P J Morris; J O Tobin
Journal:  Q J Med       Date:  1980

Review 9.  Cytomegalovirus infections following renal transplantation.

Authors:  J Glenn
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

10.  Glomerulopathy associated with cytomegalovirus viremia in renal allografts.

Authors:  W P Richardson; R B Colvin; S H Cheeseman; N E Tolkoff-Rubin; J T Herrin; A B Cosimi; A B Collins; M S Hirsch; R T McCluskey; P S Russell; R H Rubin
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245

View more
  8 in total

1.  Diagnosis of cytomegalovirus infection in heart transplant recipients.

Authors:  P S Rice; G Kudesia; C Price; G H Smith
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

2.  A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.

Authors:  T Lazzarotto; G T Maine; P Dal Monte; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

3.  Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.

Authors:  G T Maine; R Stricker; M Schuler; J Spesard; S Brojanac; B Iriarte; K Herwig; T Gramins; B Combs; J Wise; H Simmons; T Gram; J Lonze; D Ruzicki; B Byrne; J D Clifton; L E Chovan; D Wachta; C Holas; D Wang; T Wilson; S Tomazic-Allen; M A Clements; G L Wright; T Lazzarotto; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Detection of serum immunoglobulin M to human cytomegalovirus by western blotting correlates better with virological data than detection by conventional enzyme immunoassay.

Authors:  T Lazzarotto; G T Maine; P Del Monte; H Frush; K Shi; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

5.  Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.

Authors:  T Lazzarotto; C Galli; R Pulvirenti; R Rescaldani; R Vezzo; A La Gioia; C Martinelli; S La Rocca; G Agresti; L Grillner; M Nordin; M van Ranst; B Combs; G T Maine; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

6.  Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay.

Authors:  M P Landini; T Lazzarotto; G T Maine; A Ripalti; R Flanders
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

7.  Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM.

Authors:  T Lazzarotto; A Ripalti; G Bergamini; M C Battista; P Spezzacatena; F Campanini; P Pradelli; S Varani; L Gabrielli; G T Maine; M P Landini
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts.

Authors:  J M Gulizia; R Kandolf; T J Kendall; S L Thieszen; J E Wilson; S J Radio; M R Costanzo; G L Winters; L L Miller; B M McManus
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.